Lichen China Limited Announces Receipt of Nasdaq Delisting Notice Subject to Hearing Request

Lichen China Limited Announces Receipt of Nasdaq Delisting Notice Subject to Hearing Request

XIAMEN, China, Feb. 18, 2025 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has received a letter from The Nasdaq Stock...

Baidu Announces Fourth Quarter and Fiscal Year 2024 Results

Baidu Announces Fourth Quarter and Fiscal Year 2024 Results

BEIJING, Feb. 18, 2025 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"), a leading AI company with a strong Internet foundation, today announced its unaudited financial...

TigerGPT: Pioneering DeepSeek Integration for AI Chatbot, Upgrading Smart Investment Assistance

TigerGPT: Pioneering DeepSeek Integration for AI Chatbot, Upgrading Smart Investment Assistance

SINGAPORE, Feb. 18, 2025 /PRNewswire/ -- Tiger Brokers (NASDAQ: TIGR), a leading online brokerage firm, announces that its AI-powered investment assistant, TigerGPT, has officially integrated with the DeepSeek-R1 model, becoming the first global...

TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant

TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant

TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world's first Apixaban oral dissolving film (ODF). The study confirmed that TAH3311 is bioequivalent to U.S. and...

Hanon Systems Announces Full Year 2024 Financial Results

Hanon Systems Announces Full Year 2024 Financial Results

SEOUL, South Korea, Feb. 17, 2025 /PRNewswire/ -- Hanon Systems, a leading global automotive thermal management supplier and subsidiary of Hankook & Company Group, last week reported its full year 2024 financial results. For the fourth quarter...

CNOOC Limited Announces Buzios7 Project Commences Production

CNOOC Limited Announces Buzios7 Project Commences Production

HONG KONG, Feb. 17, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces that Buzios7 Project has commenced production safely. Buzios oilfield is located in the Santos Basin,...

Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results

Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results

ITASCA, Ill., Feb. 15, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two...

Australian Homes Get a Summer Floor Cleaning Revamp with Roborock's New F25 Series Wet-Dry Vacuum

Australian Homes Get a Summer Floor Cleaning Revamp with Roborock's New F25 Series Wet-Dry Vacuum

SYDNEY, Feb. 15, 2025 /PRNewswire/ -- Roborock, a global leader in ultra-intelligent home robotics engineered to simplify daily life, today announces the Australian launch of its newest wet-dry vacuum cleaner range, the F25 Series. First unveiled at...

MicroCloud Hologram Inc. announces optimization of stacked sparse autoencoders through DeepSeek model

MicroCloud Hologram Inc. announces optimization of stacked sparse autoencoders through DeepSeek model

SHENZHEN, China, Feb. 14, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, they Announced the deep optimization of stacked sparse autoencoders through the DeepSeek open-source...

IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health

IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health

SHANGHAI and NANJING, China and SAN JOSE, Calif., Feb. 14, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies...

  • 1
  • ...
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • ...
  • 152
  • menu
    menu